Understanding hypermucoviscosity in Klebsiella
了解克雷伯氏菌的高粘膜粘稠度
基本信息
- 批准号:10442731
- 负责人:
- 金额:$ 44.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-16 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntibiotic ResistanceBiological AssayCarbapenemsCenters for Disease Control and Prevention (U.S.)CharacteristicsClinicalCommunitiesComplementDataDefectDevelopmentDiseaseEnterobacteriaceaeExtended-spectrum β-lactamaseGene ExpressionGenesGenetic TranscriptionGoalsGram-Negative BacteriaImmunocompromised HostIn VitroIndividualInfectionKlebsiellaKlebsiella pneumoniaeLinkLiver AbscessLong-Term Care NursingMulti-Drug ResistanceMusNosocomial InfectionsOperonPathogenesisPhagocytesPhenotypePlasmidsPlayPolysaccharidesPrevalenceProductionPropertyProteinsReportingRoleTestingVirulenceVirulence FactorsWorkcapsulecarbapenem resistancecarbapenem-resistant Enterobacteriaceaecolistin resistancediagnostic toolextracellularhuman diseasein vivomortalitymouse modelmutantnovel therapeuticspromoterresistant Klebsiella pneumoniaeresistant straintargeted treatment
项目摘要
Abstract
Klebsiella pneumoniae (Kpn) is a leading cause of Gram-negative nosocomial infections and is associated
with a high mortality rate. Antibiotic resistance is a growing issue among the Enterobacteriaceae and of the
Enterobacteriaceae Kpn is the most prevalent extended spectrum β-lactamase and carbapenem resistant
Enterobacteriaceae isolate. The increasing prevalence of antibiotic-resistant Kpn only serves to compound its
clinical importance and to complicate treatment options. Capsule has been established as a key virulence
factor and is this species best studied virulence factor. Kpn strains are broadly classified as hypervirulent (hv)
or classical, with hv strains typically causing community acquired liver abscess and invasive infections.
Classical strains are more typically associated with nosocomial infections. The hv strains have a
hypermucoviscous (HMV) phenotype thought to be due to over-production of capsule and have acquired rmpA
that contributes to increased capsule (cps) gene expression. Most classical strains, including recent clinical
isolates associated with carbapenem resistance (ST258) are not HMV, do not have the rmpA gene and are not
virulent in mouse models of infection. Recent reports of these multidrug resistant strains acquiring the
HMV phenotype is of significant concern and amplifies the need to understand what HMV is, how it is
produced and how it contributes to virulence. Despite the apparent association between HMV and
over-production of capsule, what causes the HMV phenotype and its relationship to capsule
production is not known. Recent work from our lab using the HMV strain KPPR1S has shown that deletion of
rmpA causes decreases in expression from cps promoters, and reduction (but not complete loss) in both
capsule production and HMV. In addition, we found that rmpA is the first gene of an operon (rmpADC) and
that RmpA positively regulates expression of the operon. Results from analysis of a complete deletion of the
operon with the individual genes indicates that from this locus, RmpA primarily is required for expression of the
operon, that only RmpC is necessary for expression of cps genes, and that only RmpD is necessary for HMV.
Consistent with this, a mutant lacking only rmpD retains WT levels of cps gene expression, capsule production
and is HMV negative. The rmpD mutant is the first mutant identified that separates HMV from the over-
production of capsule, and the phenotype of the strain only expressing rmpC indicates that over-
production of capsule alone is not sufficient for HMV. Due to the importance of HMV to the virulence of hv
Kpn strains, the potential for classical strains to acquire HMV, the incomplete picture of what constitutes HMV
and what is required to produce HMV, we propose to a) gain a better understanding of RmpD, (b) characterize
the interacting partners of RmpD and how they affect HMV, and determine the composition of the HMV
exopolysaccharide, and (c) examine how HMV contributes to virulence.
抽象的
肺炎克雷伯氏菌(KPN)是革兰氏阴性症医院感染的主要原因,与之相关
死亡率高。抗生素耐药性是肠杆菌科和
肠杆菌科KPN是最普遍的扩展光谱β-内酰胺酶和碳青霉烯抗性
肠杆菌科。抗生素耐药性KPN的患病率的增加仅使其复杂化
临床重要性和使治疗选择复杂化。胶囊已成为关键病毒
因素,这是该物种最好研究的病毒因子。 KPN菌株被广泛归类为HyperVirus(HV)
或经典,HV菌株通常会导致社区获得的肝脓肿和侵袭性感染。
经典菌株通常与医院感染有关。 HV菌株有一个
高效果(HMV)表型被认为是由于胶囊过量产生的,并且已获得RMPA
这有助于增加胶囊(CPS)基因表达。大多数古典菌株,包括最近的临床
与碳青霉苯抗性相关的分离株(ST258)不是HMV,没有RMPA基因,也不是
在感染的小鼠模型中有力。最近关于这些多药抗性应变的报道
HMV表型引起了重大关注,放大器需要了解HMV是什么,它是如何的
产生及其对病毒的贡献。尽管HMV和
胶囊过量产生,导致HMV表型及其与胶囊的关系
生产尚不清楚。使用HMV菌株KPPR1S的最新工作表明删除
RMPA导致CPS启动子的表达下降,并且两者都会减少(但不是完全损失)
胶囊生产和HMV。此外,我们发现RMPA是操作系统的第一个基因(RMPADC)和
RMPA积极调节歌剧的表达。分析完全删除的结果
带有各个基因的歌剧表明,从该基因座,RMPA主要是表达的
歌剧,仅RMPC对于表达CPS基因是必需的,而HMV仅需要RMPD。
与此相一致,仅缺乏RMPD的突变体保留WT水平的CPS基因表达,胶囊产生
并为HMV负。 RMPD突变体是第一个突变体,该突变体将HMV与过度分离
胶囊的产生,仅表达RMPC的菌株的表型表明过度
仅胶囊的产生不足以用于HMV。由于HMV对HV病毒的重要性
KPN菌株是获得HMV的经典菌株的潜力,这是构成HMV的不完整图片
以及生产HMV所需的内容,我们建议a)更好地了解RMPD,(b)表征
RMPD的相互作用伙伴及其如何影响HMV,并确定HMV的组成
外多糖和(c)检查HMV如何对病毒贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIRGINIA L MILLER其他文献
VIRGINIA L MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIRGINIA L MILLER', 18)}}的其他基金
Understanding hypermucoviscosity in Klebsiella
了解克雷伯氏菌的高粘膜粘稠度
- 批准号:
10217978 - 财政年份:2020
- 资助金额:
$ 44.36万 - 项目类别:
Understanding hypermucoviscosity in Klebsiella
了解克雷伯氏菌的高粘膜粘稠度
- 批准号:
10651812 - 财政年份:2020
- 资助金额:
$ 44.36万 - 项目类别:
2016 Microbial Toxins & Pathogenicity Gordon Research Conferences and Gordon Research Seminar
2016年微生物毒素
- 批准号:
9120487 - 财政年份:2016
- 资助金额:
$ 44.36万 - 项目类别:
Factors Affecting Dissemination Events Early in Bubonic Plague
影响黑死病早期传播事件的因素
- 批准号:
8485851 - 财政年份:2013
- 资助金额:
$ 44.36万 - 项目类别:
Factors Affecting Dissemination Events Early in Bubonic Plague
影响黑死病早期传播事件的因素
- 批准号:
8605167 - 财政年份:2013
- 资助金额:
$ 44.36万 - 项目类别:
Yessinia autotransporters (Yaps): Structure, function, and host response
Yessinia 自转运蛋白 (Yaps):结构、功能和宿主响应
- 批准号:
8375890 - 财政年份:2012
- 资助金额:
$ 44.36万 - 项目类别:
Yessinia autotransporters (Yaps): Structure, function, and host response
Yessinia 自转运蛋白 (Yaps):结构、功能和宿主响应
- 批准号:
8234194 - 财政年份:2011
- 资助金额:
$ 44.36万 - 项目类别:
相似国自然基金
人工补给对地下水抗生素抗性组与病原菌的影响及调控机制
- 批准号:42377392
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
可溶态生物炭对抗生素抗性基因在水土环境中迁移与水平转移的影响及机制
- 批准号:42307468
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
邻苯二甲酸酯对噬菌体介导的抗生素抗性基因水平转移的影响和分子机制研究
- 批准号:42307292
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
冻融作用下微塑料对黑土中抗生素抗性基因赋存及迁移的影响机制研究
- 批准号:42307045
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
典型非抗生素类药物对活性污泥多质粒介导下抗生素抗性基因水平转移的影响机制研究
- 批准号:42307529
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigating metabolism and DNA damage repair in uropathogenic Escherichia coli fluoroquinolone persisters
研究泌尿道致病性大肠杆菌氟喹诺酮类持续存在的代谢和 DNA 损伤修复
- 批准号:
10747651 - 财政年份:2023
- 资助金额:
$ 44.36万 - 项目类别:
Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis
商业化准备试点 (CRP) 计划支持: 直接从样本鉴定心内膜炎常见病原体
- 批准号:
10758417 - 财政年份:2023
- 资助金额:
$ 44.36万 - 项目类别:
A Randomized Pilot and Feasibility Study of a cultuRE-Directed approach to Urinary traCT Infection symptoms in older womeN: a mixed methods evaluation - the REDUCTION trial
针对老年女性尿路感染症状的文化导向方法的随机试验和可行性研究:混合方法评估 - REDUCTION 试验
- 批准号:
10586250 - 财政年份:2023
- 资助金额:
$ 44.36万 - 项目类别:
Human Immunomics & Trained Immunity in Persistent Candidemia
人类免疫组学
- 批准号:
10551710 - 财政年份:2023
- 资助金额:
$ 44.36万 - 项目类别:
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
- 批准号:
10647072 - 财政年份:2023
- 资助金额:
$ 44.36万 - 项目类别: